Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News and Analysis
  • Published:

Economists propose a US$30 billion boost to biomedical R&D

Nature Reviews Drug Discovery volume 11, pages 735–737 (2012)Cite this article

Subjects

Economists hope they can attract billions of dollars for drug R&D by securitizing research projects. Could they close the innovation gap in the process?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Asher Mullard
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mullard, A. Economists propose a US$30 billion boost to biomedical R&D. Nat Rev Drug Discov 11, 735–737 (2012). https://doi.org/10.1038/nrd3857

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3857

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing